NCT03179904 2026-05-05TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast CancerMayo ClinicPhase 2 Active not recruiting17 enrolled 10 charts